Honorary Senior Visiting Fellow
Herman Professor of Primary Care Cancer Research, University of Melbourne
MBBCh MA MRCGP FRACGP DPhil
Jon was previously Professor of General Practice and Head of the School of Primary, Aboriginal and Rural Healthcare at the University of Western Australia before taking up the Chair of Primary Care Cancer Research at the University of Melbourne. He moved to Australia in 2004 from the University of Cambridge and has developed a joint research programme in Australia and Cambridge on cancer and genetic medicine in primary care, collaborating closely with Dr Fiona Walter. Following his medical training at Cambridge and Oxford, he has had a highly successful career in academic primary care, initially at Oxford, where he obtained his DPhil on cancer risk assessment tools, then at Cambridge before taking up the Chair at the University of Western Australia.
Jon’s research focuses on primary care oncology and the development and evaluation of complex interventions including computer decision support systems, new diagnostic and screening technologies for melanoma and bowel cancer, new models of cancer survivorship care, and the application of advances in genetic medicine in primary care.
He is one of the world’s most highly cited researchers in his discipline: for the period 2013-17, in the field of primary care, and by specific tumour stream, his international citation ranking was 1st (prostate), 2nd (breast and melanoma), 3rd (bowel) and 5th (lung).
He established and is the Director of the Cancer Australia primary care cancer clinical trials group (PC4) which currently has over 700 members and has led the development and successful funding applications for several new multidisciplinary collaborative trials. He is the Australian international partner on the Cancer Research UK funded CanTest Collaborative.
Neal RD, Sun F, Emery JD, Callister ME. Lung cancer. BMJ 2019. doi.org/10.1136/bmj.l1725
Pannebakker MM, Mills K, Johnson M, Emery JD, Walter FM. (2019) Understanding implementation and usefulness of electronic clinical decision support (eCDS) for melanoma in English primary care: a qualitative investigation. BJGP Open 19 March 2019 doi:10.3399/
Kummer S, Walter FM, Chilcot J, Emery J, Sutton S, Scott SE. (2019) Do cognitive heuristics underpin symptom appraisal for symptoms of cancer? A secondary qualitative analysis across seven cancers. Psycho‐Oncology 2019;1–7. doi: 10.1002/pon.5049
Emery JD, Murray SR, Walter FM, Martin A, Goodall S, Mazza d, Habgood E, Kutzer Y, Barnes DJ, Murchie P. (2019) The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer. Thorax, thoraxjnl-2018-212506 [Epub ahead of print]
Emery JD, Nguyen P, Minshall J, Cummings KL, Walker J. (2019) Chemoprevention: A new concept for cancer prevention in primary care. Aust J of Gen Pract 47 (12): 825
Jenkins MA, Ait Ouakrim D, Boussioutas A, Hopper JL, Ee HC, Emery JD, Macrae FA, Chetcuti A, Wuellner L, St John DJB. Revised Australian national guidelines for colorectal cancer screening: family history. Med J Aust. 2018;209(10):455-460.
Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Greuter MJE, Coupé VMH, Canfell K. Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia. Cancer Epidemiol Biomarkers Prev. 2018 Sep 6. doi: 10.1158/1055-9965.EPI-18-0128.
Humphrys E, Burt J, Rubin G, Emery JD, Walter FM. The influence of health literacy on the timely diagnosis of symptomatic cancer: A systematic review. Eur J Cancer Care (Engl). 2018 Oct 16:e12920. doi: 10.1111/ecc.12920.
Coxon D, Campbell C, Walter FM, Scott SE, Neal RD, Vedsted P, Emery J, Rubin G, Hamilton W, Weller D. (2018) The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments. BMC Health Services Research, 18(1):677. doi: 10.1186/s12913-018-3476-0
Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, … Emery JD. (2018) The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial. Trials, 19(1):397. doi: 10.1186/s13063-018-2764-7
Mazza D, Lin X, Walter FM, Young JM, Barnes DJ, Mitchell P, Brijnath B, Martin A, Emery JD. (2018) The LEAD study protocol: a mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds. BMC Cancer, 18(1):754. doi: 10.1186/s12885-018-4671-4
Dillon M, Flander L, Buchanan DD, Macrae FA, Emery JD, Winship IM, Boussioutas A, Giles GG, Hopper JL, Jenkins MA, Ait Ouakrim D. (2018) Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios. PLoS Med, Aug 16;15(8):e1002630. doi: 10.1371/journal.pmed.1002630